| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $142.9M | -3.5% |
| SG&A Expense | $54.0M | +27.1% |
| Operating Income | -$196.9M | -3.1% |
| Pre-tax Income | -$167.5M | +1.0% |
| Income Tax | $117K | +100.8% |
| Net Income | -$167.4M | -9.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $83.0M | -15.7% |
| Short-term Investments | $316.0M | -14.3% |
| Current Assets | $414.7M | -13.6% |
| Total Assets | $621.8M | +28.4% |
| Current Liabilities | $30.6M | +8.9% |
| Total Liabilities | $31.5M | +4.0% |
| Stockholders' Equity | $590.3M | +30.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$145.3M | -8.2% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$136.3M | -480.7% |
| Financing Cash Flow | $266.2M | +553.2% |
| Free Cash Flow | -$145.3M | -8.0% |